Company / Free Cash Flow per Share
Arcturus Therapeutics Holdings Inc. Free Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.76
FY2025
5-year range
-$5.29 / -$0.79
FY2021-FY2025
Trend
-22.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has fluctuated over the past 7 years, ranging from $-5.29 in FY2021 to $-0.79 in FY2023.
Based on SEC 10-K filings.
-2.76 in FY2025.
Declined from $-0.79 to $-2.76 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 22.6% year-over-year.
- Peak free cash flow per share was recorded in FY2023.
- Lowest free cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.76 | -22.6% |
| FY2024 | -$2.25 | -184.7% |
| FY2023 | -$0.79 | +84.9% |
| FY2022 | -$5.25 | +0.7% |
| FY2021 | -$5.29 | -259.8% |
| FY2020 | -$1.47 | +29.2% |
| FY2019 | -$2.07 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026